| REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs (NCT05622721) | University of Pennsylvania | 2022-05-30 |
| Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA (NCT04036058) | VA Office of Research and Development | 2022-03-29 |
| Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (NCT06258551) | The Methodist Hospital Research Institute | 2020-12-08 |
| Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea (NCT02801656) | Memorial University of Newfoundland | 2020-12-01 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection (NCT04100603) | ProgenaBiome | 2020-03-02 |
| Randomized Clinical Trial of Standard FMT Treatments (NCT04729790) | The University of Texas Health Science Center, Houston | 2020-01-10 |
| Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics. (NCT03937999) | Montefiore Medical Center | 2019-08-30 |
| Oligosaccharide for Cdiff(+) Heme-onc Patients (NCT03778606) | Medical College of Wisconsin | 2019-06-01 |
| FQ Restriction for the Prevention of CDI (NCT03848689) | University of Wisconsin, Madison | 2019-05-01 |
| Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT03788434) | Vedanta Biosciences, Inc. | 2019-02-08 |
| Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection (NCT03760484) | University of Alberta | 2019-01-21 |
| C Difficile Near-patient Diagnostics (NCT03857464) | University of Calgary | 2019-01-15 |
| PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol (NCT03617172) | Vanderbilt University Medical Center | 2018-11-26 |
| Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection (NCT03586206) | Roma Tre University | 2018-09-15 |
| Clostridium Difficile Virulence Mechanism Study (CDVM Study) (NCT03654872) | Chinese University of Hong Kong | 2018-06-30 |
| Digestive Microbiota Transplant (NCT03606031) | Assistance Publique Hopitaux De Marseille | 2018-03-23 |
| Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain (NCT03368105) | Medical University of Silesia | 2018-01-01 |
| Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections (NCT03223415) | Yves Longtin | 2017-08-25 |
| Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections (NCT02774382) | Hvidovre University Hospital | 2017-05-01 |
| Immune Response to C.Difficile Infection (NCT02797288) | University of Virginia | 2017-03-22 |
| Antimicrobial Stewardship Program for Clostridium Difficile Infection. (NCT02951481) | José María Aguado García, MD, PhD | 2017-02-15 |
| Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics (NCT03117582) | University of North Carolina, Chapel Hill | 2016-12-01 |
| AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment (NCT02896244) | MJM Bonten | 2016-09-27 |
| Intestinal Lavage for the Treatment of Severe C. Difficile Infections (NCT02466698) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-08-01 |
| Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection (NCT03427229) | Catholic University of the Sacred Heart | 2016-03-01 |
| Fecal Microbiome Transplant (NCT02636517) | Judith Kelsen | 2015-12-01 |
| To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients (NCT02730325) | Northwestern University | 2015-12-01 |
| A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI (NCT02563106) | Theriva Biologics, Inc. | 2015-10-01 |
| Chlorhexidine Bathing Effect on Clostridium Difficile Rates (NCT02502682) | Jared Brooks | 2015-07-01 |
| Early FMT for C.Difficile (NCT02465463) | Emory University | 2015-06-01 |
| SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) (NCT02437487) | Seres Therapeutics, Inc. | 2015-05-01 |
| Fresh Versus Frozen Stool for Fecal Transplant in Children (NCT02423967) | Mayo Clinic | 2015-04-01 |
| Probiotics in the Reduction of Antibiotic Associated Diarrhea (NCT02589964) | TriHealth Inc. | 2015-03-01 |
| Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection (NCT02403622) | Microbiome Health Research Institute | 2015-03-01 |
| Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods (NCT02375477) | Case Comprehensive Cancer Center | 2015-01-27 |
| Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum (NCT02343328) | Massachusetts General Hospital | 2015-01-01 |
| Dose-Confirmation, Immunogenicity and Safety Study of the Clostridium Difficile Vaccine Candidate VLA84 in Healthy Adults Aged 50 Years and Older. Phase II Study (NCT02316470) | Valneva Austria GmbH | 2014-12-01 |
| A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population (NCT02254967) | Astellas Pharma Europe Ltd. | 2014-11-06 |
| Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly (NCT02207140) | Gabriella C. van Zanten | 2014-10-01 |
| Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile (NCT02857582) | Per Hellström | 2014-10-01 |
| Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy (NCT02247960) | University of Rochester | 2014-07-01 |
| A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD) (NCT02179658) | Astellas Pharma Inc | 2014-06-23 |
| Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis (NCT01959048) | Hadassah Medical Organization | 2014-04-01 |
| Mucosal Versus Fecal Microbiota in FMT (NCT02133651) | Emory University | 2014-04-01 |
| Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients. (NCT03889808) | Hospital Universitari de Bellvitge | 2014-03-01 |
| A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection (NCT02394275) | McMaster University | 2014-03-01 |
| The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers (NCT02063282) | Amos Yinnon | 2014-02-01 |
| Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury (NCT02355938) | Baylor College of Medicine | 2014-02-01 |
| A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine. (NCT02052726) | Pfizer | 2014-01-22 |
| Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection (NCT02134392) | Jonathan Gisser | 2013-12-01 |
| Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis (NCT01942447) | University Hospital Tuebingen | 2013-10-01 |
| Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis (NCT01973465) | OSF Healthcare System | 2013-09-01 |
| Effects of Gastric Acid on Colonic Microbiome (NCT01901276) | Daniel Freedberg, MD | 2013-08-01 |
| Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection (NCT02148601) | Catholic University of the Sacred Heart | 2013-07-01 |
| Probiotics for Clostridium Difficile Infection in Older Adults (NCT01680874) | University of Wisconsin, Madison | 2013-02-01 |
| A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (NCT01775397) | Astellas Pharma Europe Ltd. | 2012-11-29 |
| Fecal Transplant for Relapsing C. Difficile Infection (NCT01703494) | Colleen Kelly | 2012-10-01 |
| Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly (NCT01048567) | Vancouver Island Health Authority | 2011-09-01 |
| Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) (NCT01401023) | Gary E. Stein, Pharm.D. | 2011-07-01 |
| Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea (NCT01143272) | Bernhard Nocht Institute for Tropical Medicine | 2010-06-01 |
| Probiotics in Preventing Antibiotic Associated Diarrhoea Including Clostridium Difficile Infection (NCT01087892) | University of Sussex | 2009-10-01 |
| Comparative Study of Three Different Testing Mechanisms for Clostridium Difficile (NCT01066221) | Hamilton Health Sciences Corporation | 2009-09-01 |
| Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy (NCT00591357) | Michael E. DeBakey VA Medical Center | 2007-10-01 |
| Probiotics: is it Really That Good? Cost-Effectiveness of Treating the in-Patient (NCT00506181) | Hadassah Medical Organization | 2007-07-01 |
| A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea (NCT00466635) | Genzyme, a Sanofi Company | 2007-04-01 |
| Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation (NCT00566306) | University of Helsinki | 2007-02-01 |
| Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile. (NCT00377078) | Johns Hopkins University | 2005-10-01 |
| Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis (NCT00417872) | Romark Laboratories L.C. | 2004-01-01 |